The kidney is innervated with efferent sympathetic nerve fibers that directly contact the vasculature, the renal tubules, and the juxtaglomerular granular cells. Via specific …
H Castrop, K Höcherl, A Kurtz… - Physiological …, 2010 - journals.physiology.org
The protease renin is the key enzyme of the renin-angiotensin-aldosterone cascade, which is relevant under both physiological and pathophysiological settings. The kidney is the only …
PB Persson - The Journal of physiology, 2003 - Wiley Online Library
Renin is a central hormone in the control of blood pressure and various other physiological functions. In spite of the very early discovery of renin over 100 years ago, we have only …
M Lu, YH Liu, HS Goh, JJX Wang… - Journal of the …, 2010 - journals.lww.com
The development of renovascular hypertension depends on the release of renin from the juxtaglomerular (JG) cells, a process regulated by intracellular cAMP. Hydrogen sulfide (H 2 …
F Schweda, U Friis, C Wagner, O Skott… - Physiology, 2007 - journals.physiology.org
The aspartyl-protease renin is the key regulator of the renin-angiotensin-aldosterone system, which is critically involved in salt, volume, and blood pressure homeostasis of the …
S Bernardi, A Michelli, G Zuolo… - Journal of diabetes …, 2016 - Wiley Online Library
Since the advent of insulin, the improvements in diabetes detection and the therapies to treat hyperglycemia have reduced the mortality of acute metabolic emergencies, such that today …
A Kurtz - Annual review of physiology, 2011 - annualreviews.org
In the adult organism, systemically circulating renin almost exclusively originates from the juxtaglomerular cells in the afferent arterioles of the kidneys. These cells share similarities …
A Kurtz - American journal of hypertension, 2012 - academic.oup.com
The aspartyl protease renin is the rate limiting activity of the renin–angiotensin–aldosterone system (RAAS). Renin is synthesized as an enzymatically inactive proenzyme which is …
M Ercu, MB Mücke, T Pallien, L Markó, A Sholokh… - Circulation, 2022 - Am Heart Assoc
Background: Phosphodiesterase 3A (PDE3A) gain-of-function mutations cause hypertension with brachydactyly (HTNB) and lead to stroke. Increased peripheral vascular …